KZR insider transaction filings
Kezar Life Sciences, Inc. — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-11. Screen KZR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-11 | 4 | Chiang Pichi Luo — SVP, Corporate Controller | Code (U): 2,711 · Disposition to issuer (D): 10,000 (derivative) @ $0 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 17,500 (derivative) @ $0 · Disposition to issuer (D): 7,500 (derivative) @ $0 · Disposition to issuer (D): 1,199 (derivative) @ $0 · +8 more | EDGAR |
| 2026-05-11 | 4 | Schiller Mark C. — Chief Operating Officer | Code (U): 2,739 · Disposition to issuer (D): 25,000 (derivative) @ $0 · Disposition to issuer (D): 24,500 (derivative) @ $0 · Disposition to issuer (D): 12,000 (derivative) @ $0 · Disposition to issuer (D): 4,999 (derivative) @ $0 · Disposition to issuer (D): 2,499 (derivative) @ $0 · +4 more | EDGAR |
| 2026-05-11 | 4 | Klearman Micki — Director | Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,200 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Wallace Courtney — Director | Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,200 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 | EDGAR |
| 2026-05-11 | 4 | Fowler John Franklin — Director | Code (U): 39,390 · Code (U): 375 · Code (U): 3,846 · Disposition to issuer (D): 4,893 (derivative) @ $0 · Disposition to issuer (D): 17,792 (derivative) @ $0 · Disposition to issuer (D): 8,896 (derivative) @ $0 · +8 more | EDGAR |
| 2026-05-11 | 4 | Kirk Christopher J. — CEO, Director | Code (U): 43,134 · Disposition to issuer (D): 4,448 (derivative) @ $0 · Disposition to issuer (D): 17,792 (derivative) @ $0 · Disposition to issuer (D): 8,896 (derivative) @ $0 · Disposition to issuer (D): 7,117 (derivative) @ $0 · Disposition to issuer (D): 87,499 (derivative) @ $0 · +6 more | EDGAR |
| 2026-05-11 | 4 | Garner Elizabeth — Director | Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 1,779 (derivative) @ $0 · Disposition to issuer (D): 889 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · +1 more | EDGAR |
| 2026-05-11 | 4 | COOPER GRAHAM K — Director | Disposition to issuer (D): 3,742 (derivative) @ $0 · Disposition to issuer (D): 889 (derivative) @ $0 · Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 889 (derivative) @ $0 · +4 more | EDGAR |
| 2026-05-11 | 4 | Belsky Marc — Chief Financial Officer | Code (U): 1,538 · Code (U): 200 · Disposition to issuer (D): 17,793 (derivative) @ $0 · Disposition to issuer (D): 29,499 (derivative) @ $0 · Disposition to issuer (D): 24,500 (derivative) @ $0 · Disposition to issuer (D): 12,000 (derivative) @ $0 · +6 more | EDGAR |
| 2026-05-11 | 4 | Kauffman Michael — Director | Code (U): 6,369 · Disposition to issuer (D): 389 (derivative) @ $0 · Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 889 (derivative) @ $0 · +3 more | EDGAR |
| 2026-05-11 | 4 | BERGER FRANKLIN M — Director | Code (U): 89,069 · Disposition to issuer (D): 3,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 · Disposition to issuer (D): 2,600 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Chiang Pichi Luo — SVP, Corporate Controller | Sale (S): 264 @ $4.28 | EDGAR |
| 2025-07-03 | 4 | Schiller Mark C. — Chief Operating Officer | Sale (S): 561 @ $4.28 | EDGAR |
| 2025-07-01 | 4 | To Zung Phuong — Chief Development Officer | Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Klearman Micki — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Wallace Courtney — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Fowler John Franklin — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Garner Elizabeth — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | COOPER GRAHAM K — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | Kauffman Michael — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | BERGER FRANKLIN M — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Schiller Mark C. — Chief Legal Officer | Grant/award (A): 4,800 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Belsky Marc — Chief Financial Officer | Grant/award (A): 4,800 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Schiller Mark C. — Chief Legal Officer | Grant/award (A): 7,200 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Belsky Marc — Chief Financial Officer | Grant/award (A): 7,200 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Fowler John Franklin — Director | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Kezar Life Sciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-05-11 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-07 | 8-K | ? | EDGAR |
| 2025-10-22 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-10-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.03 — Material Modification to Rights of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-23 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KZR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →